Prognos Blog
Deterministic or predictive profiles? How to optimize your HCP promotional activities across channels
We’re excited to share part three of our blog series about one of the most promising methodologies for life science...
What to Consider if Your Drug is a Targeted Therapy for a New Biomarker
A Follow Up to “Biomarker Testing in Non-Small Cell Lung Cancer“ By Melissa Leonhauser, General Manager, Alert & Targeting Portfolio...
Highlights from RISE Nashville 2019
By Asher Gendelman, VP of Payer Sales Once again, RISE Nashville delivered rich content, deep discussions, and fantastic networking. The...
Available Omnichannel HCP Data Sources
Clinical Diagnostic Data for Omnichannel HCP Promotion Marketing: Part Two We’re excited to share part two of our blog series...
Biomarker Testing in Non-Small Cell Lung Cancer
By Bill Bowman, Clinical Solutions Architect The trend toward precision medicine in oncology is epitomized by the management of patients...
Rare Disease Day 2019
By Sanjiv Lall Every year we see new breakthroughs in medical science that allow us to treat, and sometimes even...
Clinical Diagnostic Data for Omnichannel HCP Marketing
A 5 Part Series By Matt Apprendi, VP of Digital Products We’re excited to write about one of the most...
Innovative Models for Converting AI Data
Wouldn’t it be convenient if a doctor could simply upload a patient’s medical chart into an artificial intelligence (AI) system,...
How Lab Data Can Identify Risk Among Medicare Advantage Members
By Frank Jackson, EVP, Payer Markets When payers are identifying risk in Medicare, they start with the most easily accessible...
Reflections on the PMSA Winter Symposium
By Theresa Greco, Chief Commercial Officer The PMSA Winter Symposium, “Innovation in Analytics via Machine Learning & AI” brought together...